Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Glycopeptide Antibiotics Market Expected to Be in 2029?

In recent times, the glycopeptide antibiotics market has been experiencing robust growth. The market, which was worth $3.54 billion in 2024, is anticipated to increase to $3.78 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 7.0%. The factors contributing to the growth during the historic period include the rising antibiotic resistance, the surge in infectious diseases, supportive governmental initiatives, increased healthcare expenses, and the global spread of infectious diseases.

The market size for glycopeptide antibiotics is forecasted to significantly expand in the ensuing years. It is projected to reach $5.38 billion in 2029, with a compound annual growth rate (CAGR) of 9.2%. This anticipated growth during the forecast period can be primarily attributed to the rise of new infectious diseases, an aging population, ongoing issues with antibiotic resistance, investments and advancements in research and development, and the growth of healthcare infrastructure. Key trends expected during this period include growing antibiotic resistance, progress in research and development, the demand spurred by global health crises, collaboration efforts for antibiotic management, and market growth in developing economies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9444&type=smp

What Are The Contributors To Demand In The Glycopeptide Antibiotics Market?

Escalating cancer and infectious disease cases are predicted to stimulate the expansion of the glycopeptide antibiotics market. Cancer is a condition characterized by unrestricted proliferation and spread of certain body cells to different regions in the body. Conversely, infectious diseases are ailments induced by organisms like bacteria, viruses, fungi, or parasites. Glycopeptide antibiotics, used in the treatment of infectious ailments caused by methicillin-resistant staphylococcus aureus, streptococcus, or enterococcus bacteria resistant to beta-lactams and other antibiotics, are crucial in this landscape. For cancer patients, the antibiotics enhance the effectiveness of radiotherapy by removing not only the targeted tumour cells but also distant cancer cells deep within the body. An example is the data from the American Cancer Society, a US-based not-for-profit health organization committed to eradicating cancer. This body recorded 1.9 million new cancer cases and 609,360 cancer deaths in the US in 2022, amounting to 1,670 deaths daily. So, the increasing prevalence of cancer and infectious diseases is set to accelerate the growth of the glycopeptide antibiotics market.

What Segmentation Categories Are Included In The Glycopeptide Antibiotics Market Analysis?

The glycopeptide antibiotics market covered in this report is segmented –

1) By Drug: Vancomycin, Dalbavancin, Oritavancin, Other Drugs

2) By Route of Administration: Oral, Parenteral, Other Routes

3) By Indication: Skin And Structure Infection, Meningitis, Clostridioides Difficile Infection, Enterocolitis, Other Indications

4) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Vancomycin: Vancomycin Injection, Vancomycin Oral Solution, Vancomycin Capsules, Vancomycin Powder for Solution

2) By Dalbavancin: Dalbavancin IV (Intravenous) Formulation, Dalbavancin Powder for Injection

3) By Oritavancin: Oritavancin IV (Intravenous) Formulation,Oritavancin Powder for Injection

4) By Other Drugs: Teicoplanin, Linezolid, Daptomycin, Other Glycopeptide and Lipoglycopeptide Antibiotics

4o

What Upcoming Trends Are Expected To Impact The Glycopeptide Antibiotics Market Globally?

The enhancement of product creativity is an emerging trend noticed within the glycopeptide antibiotics market. Giant corporations within the market are investing in the development of innovative medicines to secure their market standing. For example, in October 2022, Leiden University, based in the Netherlands, introduced new forms of the antibiotic, vancomycin. By attaching a set of molecules to an existing vancomycin molecule, they were successful in creating an upgraded version of the antibiotic vancomycin. The new strand of vancomycin is found to be considerably more potent against gram-positive bacteria, by up to a thousand times, than its previous version. It also exhibits lower degrees of nephrotoxicity compared to the commonly-used polymyxin antibiotics. Also, it was developed to overcome the limitation of vancomycin that is only potent against gram-positive strains and incapable of penetrating the outer membrane of gram-negative bacteria.

Who Are The Top-Ranked Companies In The Glycopeptide Antibiotics Market Today?

Major companies operating in the glycopeptide antibiotics market include ANI Pharmaceuticals Inc., Fresenius SE & Co. KGaA, Pfizer Inc., Novartis AG, Hikma Pharmaceuticals Plc., Aurobindo Pharma Limited, Abbvie Inc., Cumberland Pharmaceuticals Inc., Janssen Global, Bristol-Myers Squibb Company, Shenwei Pharmaceutical Hainan Co. Ltd., Zhejiang Hisun Pharmaceutical Co. Ltd., Alvogen, Bayer AG, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Sanofi SA, GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca, Boehringer Ingelheim GmbH, Cipla Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/glycopeptide-antibiotics-global-market-report

How Is Glycopeptide Antibiotics Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the glycopeptide antibiotics market in 2024. The regions covered in the glycopeptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9444&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model